Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621242 · ClinicalTrials.gov registry record
Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 9
- Enrollment target
NCT02621242 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 9 participants.
The verdict
NCT02621242 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
As explained in detail in a recently published hypothesis article (Hladik F. A new hypothesis on HIV cure. F1000Research, 4:77 (2015)), the investigators hypothesize that NRTI drugs may reduce the likelihood of HIV eradication by promoting the survival of cells with integrated provirus. In this study, the investigators will test whether daily oral use of two NTRI drugs, tenofovir and emtricitabine (Truvada Pill), induces changes in the upper and lower gut mucosa that are congruent with supporting this hypothesis.
Interventions
- PROCEDURE Anoscopy
- DRUG Truvada
- PROCEDURE Upper endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02621242
The ClinicalTrials.gov registry entry for NCT02621242 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Anoscopy is the first listed.
NCT02621242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02621242 about?
NCT02621242 is a clinical study titled "Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals". As explained in detail in a recently published hypothesis article (Hladik F. A new hypothesis on HIV cure. F1000Research, 4:77 (2015)), the investigators hypothesize that NRTI drugs may reduce the likelihood of HIV eradication by promoting the survival of cells with integrated provirus. In this stud...
What is the current status of trial NCT02621242?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2015-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02621242?
The interventions under investigation include: Anoscopy (PROCEDURE), Truvada (DRUG), Upper endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02621242?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.